Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission
Rodrigo Martino(Universitat Autònoma de Barcelona), Jorge Sierra(Universitat Autònoma de Barcelona), Salut Brunet(Institut Català d'Oncologia), David Valcárcel(Vall d'Hebron Hospital Universitari), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge)
Cited by 65
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k